Project description
International cooperation in strengthening personalised medicine policies
Personalised medicine (PM) is an emerging approach to disease prevention and treatment that considers the variability in the genetic, environmental and lifestyle makeup of each individual. PM will benefit patients, healthcare systems and healthcare industries as a whole. The patients can get better treatment in terms of improved efficacy and safety via better-targeted therapies and disease intervention. The healthcare systems can benefit from improved diagnoses and more efficient allocation of healthcare resources, preventing or delaying more expensive treatments. The EU-funded EULAC-PerMed project will create the International Consortium on Personalised Medicine for Latin American and Caribbean states, widening the scope of PM research- and innovation-related policies.
Fields of science
Programme(s)
Funding Scheme
CSA - Coordination and support actionCoordinator
28029 Madrid
Spain
See on map
Participants (12)
51147 Koln
See on map
21040 900 Rio De Janeiro
See on map
00144 Roma
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
00184 Roma
See on map
Participation ended
8340486 Santiago
28760 Tres Cantos
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
75014 Paris
See on map
11500 Montevideo
See on map
0816 Panama
See on map
9101002 Jerusalem
See on map
1425 Ciudad Autonoma De Buenos Aires
See on map
8340486 Santiago
See on map